Observational Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Oct 21, 2020; 26(39): 6074-6086
Published online Oct 21, 2020. doi: 10.3748/wjg.v26.i39.6074
Figure 2
Figure 2 Prediction model of gastroesophageal reflux disease -related medical utilization using a univariate generalized additive Poisson regression model. A: Gastroesophageal reflux disease (GERD)-related medical utilizations with AT; B: GERD-related medical utilizations as with particulate matter with a diameter ≤ 2.5 µm levels ≤ 40 μg/m3; C: GERD-related medical utilizations in the range of the IQR for carbon monoxide. CO: Carbon monoxide; PM2.5: Particulate matter with a diameter ≤ 2.5 µm; ppm: Parts-per-million.